Search

everythinglearnresearchcommunity

for

Search:↓

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

The conclusions are: fecal short-chain fatty acids may help prevent cancer, fiber intake can reduce obesity, weight loss is hard for obese people, low BMI cancer patients are more prone to chemotherapy side effects, intermittent fasting benefits gut health, cherry laurel has health benefits in rats, certain gene variations can increase stress in hair loss patients, fecal acids can affect blood sugar levels, cold agglutinin can affect blood test results in autoimmune patients, and people with Crohn's disease have higher levels of a certain chemical in their blood.

Long-term use of androgens can help manage Hereditary Angioedema (HAE) but may cause serious side effects, so alternative treatments with fewer side effects are being considered.

Hair loss can be managed with treatments like minoxidil, finasteride, and others, but there are still gaps in effectiveness and off-label usage is increasing.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The conference concluded with plans for joint research into children's skin conditions and emphasized the importance of collaboration and patient-focused research.

The document concludes that personalized treatment plans for hair loss in Asian men are necessary and more research is needed to develop effective guidelines.

The developed system could effectively treat hair loss and promote hair growth.

Chitosan-decorated finasteride nanosystems improve skin retention and could be a better treatment for hair loss.

Chitosan hydrogels are promising for repairing blood vessels but need improvements in strength and compatibility.

Valproate sustained-release is effective and generally safe for short-term treatment of new partial epilepsy.

Particle properties affect drug retention and release in minoxidil foams, with lipid nanoparticles having higher loading capacity.

Niosomes are a promising and effective way to deliver drugs through the skin.

Ethosomes improve drug delivery through the skin but may have side effects like irritation.

The flutamide-loaded hydrogel is a promising, skin-friendly treatment for acne and hair loss, potentially requiring less frequent application.

Scientists developed a new method to deliver alopecia treatment directly to hair follicles, which could be a promising treatment for hair loss and other hair diseases.

Cooling the scalp below 22°C before and during chemotherapy can help prevent hair loss.

Chitosan-decorated polymersomes improve finasteride delivery for hair loss treatment.

Nanostructured lipid carriers improve minoxidil delivery for hair loss treatment.

Nanoemulgel is a better way to deliver drugs through the skin for various conditions.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.

Liposomes improve the delivery and effectiveness of cosmetic ingredients but face challenges like cost and stability.

Liposomes improve finasteride delivery for hair loss treatment, making it a promising option for topical use.

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

Oleic acid nanovesicles improve minoxidil absorption in hair follicles for alopecia treatment.

New gel formulas without ethanol and propylene glycol, containing a minoxidil-methyl-β-cyclodextrin complex, have been created for treating hair loss.

New hair follicle-targeting treatments show promise for hair disorders but need more research on safety and effectiveness.

Nanoparticle-based drug delivery to hair follicles is more effective when tested under conditions that match skin behavior.

Polymeric nanohydrogels show potential for skin drug delivery but have concerns like toxicity and regulatory hurdles.